Total Payments
$876.17
2024 Payments
$82.30
Companies
13
Transactions
49
Medicare Patients
1,222
Medicare Billing
$97,130
Payment Breakdown by Category
Food & Beverage$876.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $876.17 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $202.95 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $151.57 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $124.63 | 2 | $0 (2022) |
| GENZYME CORPORATION | $69.30 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.52 | 2 | $0 (2023) |
| ALK-Abello, Inc | $49.55 | 3 | $0 (2022) |
| kaleo, Inc. | $44.97 | 3 | $0 (2022) |
| Aimmune Therapeutics, Inc. | $44.93 | 3 | $0 (2022) |
| CSL Behring | $44.77 | 2 | $0 (2022) |
| Covis Pharma GmBH | $35.80 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82.30 | 5 | GlaxoSmithKline, LLC. ($62.31) |
| 2023 | $197.26 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($55.52) |
| 2022 | $312.64 | 14 | Regeneron Healthcare Solutions, Inc. ($124.63) |
| 2021 | $283.97 | 19 | Optinose US, Inc. ($112.84) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Immunology | ||||||
| 11/20/2023 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/07/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: IMMUNOLOGY | ||||||
| 03/13/2023 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/23/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 02/20/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/12/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2022 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Allergy | ||||||
| 11/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2022 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Allergy and Immunology | ||||||
| 10/14/2022 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Allergy and Immunology | ||||||
| 10/07/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: ALLERGY | ||||||
| 09/01/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2022 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 427 | 517 | $129,142 | $34,574 |
| 2022 | 8 | 331 | 381 | $100,618 | $27,222 |
| 2021 | 7 | 225 | 249 | $69,798 | $19,467 |
| 2020 | 9 | 239 | 270 | $65,308 | $15,867 |
Total Patients
1,222
Total Services
1,417
Medicare Billing
$97,130
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 204 | $41,208 | $12,220 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $34,220 | $8,020 | 23.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $19,605 | $4,668 | 23.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 28 | 31 | $7,750 | $2,652 | 34.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $5,681 | $1,770 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 23 | $4,271 | $1,289 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 33 | $4,125 | $1,235 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,540 | $1,053 | 29.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $4,992 | $976.04 | 19.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2023 | 13 | 15 | $3,750 | $691.18 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 139 | $28,078 | $8,345 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $25,370 | $6,428 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $21,520 | $5,596 | 26.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,824 | $1,552 | 26.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 14 | 14 | $3,500 | $1,340 | 38.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 23 | 25 | $6,250 | $1,238 | 19.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 25 | $2,885 | $1,047 | 36.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 17 | $3,239 | $864.90 | 26.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 19 | 19 | $3,952 | $811.46 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 89 | $17,978 | $5,547 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 27 | $14,526 | $3,761 | 25.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 49 | 49 | $14,335 | $3,694 | 25.8% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 21 | 22 | $5,500 | $2,127 | 38.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $5,824 | $1,490 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 17 | $5,015 | $1,350 | 26.9% |
About Heather Rozencwaig, APN
Heather Rozencwaig, APN is a Family healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043478100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Rozencwaig, APN has received a total of $876.17 in payments from pharmaceutical and medical device companies, with $82.30 received in 2024. These payments were reported across 49 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($876.17).
As a Medicare-enrolled provider, Rozencwaig has provided services to 1,222 Medicare beneficiaries, totaling 1,417 services with total Medicare billing of $97,130. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Voorhees, NJ
- Active Since 05/27/2008
- Last Updated 10/18/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043478100
Products in Payments
- Xhance (Drug) $202.95
- DUPIXENT (Biological) $193.93
- NUCALA (Biological) $121.26
- Odactra (Drug) $49.55
- AUVI-Q (Drug) $44.97
- PALFORZIA (Biological) $44.93
- Hizentra (Biological) $44.77
- ALVESCO (Drug) $35.80
- CUVITRU (Biological) $30.82
- TRELEGY ELLIPTA (Drug) $30.31
- XPRESS ENT DILATION SYSTEM (Device) $25.95
- HYQVIA (Biological) $24.70
- Ryaltris (Drug) $13.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Voorhees
Rachelle Coughlin, Np-C, NP-C
Family — Payments: $3,158
Family $3,158
Natalie Dwier, Fnp-Bc, FNP-BC
Family — Payments: $2,553
Family $2,553
Ms. Taryn Lamorte, Fnp-C, FNP-C
Family — Payments: $2,326
Family $2,326
Norma Mann, Apn, APN
Family — Payments: $2,180
Family $2,180
Cheri Jackson
Family — Payments: $1,943
Family $1,943
Mrs. Margaret Leiter, Apn, APN
Family — Payments: $1,512
Family $1,512